Moreover, the level of CD200, together with its receptor, CD200R, has been reported to be decreased in Alzheimer’s disease (AD), a neurodegenerative disease, that is characterized by ongoing chronic inflammation in the brain lesions [32, 55]. The gene discussed is CD200R1; the disease is early-onset autosomal dominant Alzheimer disease.